In this study, we demonstrate that conditional deletion of LSD1 in the myeloid lineage confers protection against inflammatory bone loss in two distinct murine models of osteolytic disease: LIP and K/BxN serum-transfer arthritis. The gene discussed is KDM1A; the disease is medical procedure.